Iovance Biotherapeutics, INC.
Development and commercialization of immunotherapies
Based in CA
🤖
AI Overview
With $420K in lobbying spend across 12 quarterly filings, Iovance Biotherapeutics, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2023.
$420K
Total Spend
4
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $30K |
| 2021 | $190K |
| 2022 | $200K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
- •Education around tumor infiltrating lymphocytes (TIL) cancer therapies
- •Education around tumor infiltrating lymphocytes (TIL) cancer therapies;
- •H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260)
- •Education around tumor infiltrating lymphocytes (TIL) cancer therapies;
- •H.R. 1319, American Rescue Plan Act of 2021 (PL 117-2);
- •Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116
- •Education around tumor infiltrating lymphocytes (TIL) cancer therapies;
- •Implementation of American Rescue Plan Act of 2021 (PL 117-2);
- •Continued monitoring of Consolidated Appropriations Act, 2021
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.